Sustained Virologic Response [setrvalá virologická odpověď]

topical
20
Terms

Sustained Viral Suppression

Definition

The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS.

DUI
D000072230 MeSH Browser
CUI
M000616660
Previous indexing
Antiviral Agents/therapeutic use (1999-2016); Drug Therapy, Combination (1999-2016); Treatment Outcome (1999-2016)
History note
2017
Public note
2017

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E01 Diagnosis 1 793
E01.789 Prognosis 9 717
E01.789.800 Treatment Outcome 21 809
E01.789.800.190 Disease-Free Survival 1 449
E01.789.800.285 Progression-Free Survival 520
E01.789.800.665 Therapeutic Index 6
E01.789.800.713 Treatment Expectations
E01.789.800.760 Treatment Failure 686

N Health Care
N04.761.559.590.800 Treatment Outcome 21 809
N04.761.559.590.800.190 Disease-Free Survival 1 449
N04.761.559.590.800.379 Early Termination of Clinical Trials 16
N04.761.559.590.800.427 Pathologic Complete Response 7
N04.761.559.590.800.474 Progression-Free Survival 520
N04.761.559.590.800.665 Sustained Virologic Response 20
N04.761.559.590.800.713 Therapeutic Index 6
N04.761.559.590.800.737 Treatment Expectations
N04.761.559.590.800.760 Treatment Failure 686
N05.715.360.575.575 Outcome Assessment, Health Care 587
N05.715.360.575.575.800 Treatment Outcome 21 809
N05.715.360.575.575.800.190 Disease-Free Survival 1 449
N05.715.360.575.575.800.379 Early Termination of Clinical Trials 16
N05.715.360.575.575.800.427 Pathologic Complete Response 7
N05.715.360.575.575.800.474 Progression-Free Survival 520
N05.715.360.575.575.800.569 Response Evaluation Criteria in Solid Tumors 42
N05.715.360.575.575.800.665 Sustained Virologic Response 20
N05.715.360.575.575.800.713 Therapeutic Index 6
N05.715.360.575.575.800.737 Treatment Effect Heterogeneity
N05.715.360.575.575.800.749 Treatment Expectations
N05.715.360.575.575.800.760 Treatment Failure 686